InSysBio to present at PAGE 2019

events
Conference
June 5, 2019

June 5, 2019

InSysBio announces their participation at PAGE 2019 28th Meeting being held from 11 to 14 June 2019 in Stockholm, Sweden. InSysBio is presenting five posters:

Wednesday, June 12 (9:50-11:15):

  • I-86: “Investigation of dose response behavior of bispecific T-cell engaging antibodies using quantitative systems pharmacology modeling” (view abstract) by Oleg Demin Jr and Dmitry Shchelokov

Wednesday, June 12 (15:10-16:40):

  • II-42: “Quantitative Systems Pharmacology model of key intraneuronal pathways regulating toxic protein accumulation” (view abstract) by Mark Meerson, Tatiana Karelina and Diana Сlausznitzer (Abbvie)

Thursday, June 13 (9:55-11:20):

  • III-16: “Physiologically based pharmacokinetic modeling of anti-PD-1 therapeutic antibodies” (view abstract) by Dmitry Shchelokov and Oleg Demin Jr

Thursday, June 13 (15:25-16:50):

  • IV-74: “Amyloid ? in vitro prion properties and in vivo pathology exacerbation mechanisms studied by translation quantitative systems pharmacology model for prediction of anti-protofibril immunotherapy effects” (view abstract) by Tatiana Karelina

  • V-89: “Application of different approaches to generate virtual patient populations for QSP model of physiologically based pharmacokinetic model of anti-PD-1 therapeutic antibodies” (view abstract) by Galina Kolesova, Oleg Demin, Evgeny Metelkin and Dmitry Shchelokov

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative approach has already become a part of the drug development process implemented by our strategic partners: nowadays there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. The company has published multiple scientific studies in various therapeutic areas. InSysBio team is developing software and tools for QSP and continuously improves methods for biological modeling. For more information about InSysBio, its solutions and services, visit insysbio.com.

March 2020
MoTuWeThFrSaSu
      
1
2
3
1. 03 Mar 2020 12:25 13th InSysBio Annual Internal Scientific Meeting 26-28 February 2020 InSysBio QSP-company held its 13th Annual Internal Scientific Meeting. InSysBio team presented the results of 2019 year professional progress. Every member demonstrated their personal achievements and shared the plans for the future development. Oleg Demin, InSysBio CEO and founder, summarized all the company’s advancement of the year 2019.
4
5
6
7
8
9
10
1. 10 Mar 2020 12:48 InSysBio to share the news from QSPC2020 management Today we have received the concerning news from QSPC2020 organizers about the cancellation of the conference in response to COVID-19 outbreak continuation. Quantitative Systems Pharmacology Conference 2020 was planned to be held in April 22-24, 2020 Leiden, The Netherlands. InSysBio team was prepared to present 10 posters
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
     
Upcoming Events
Tags
Latest News
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha
18.06
InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology
03.06
InSysBio to present Integration of Cytocon DB and fIVE DB with Heta for QSP modeling
30.05
InSysBio to publish the new article in CPT: Clinical Pharmacology & Therapeutics
15.05
15th InSysBio’s Annual Internal Scientific Meeting